InVivo Therapeutics Holdings Corp. (NVIV) Forms $1.58 Double Bottom; Earnest Partners Cut By $1.43 Million Its Mednax (MD) Stake

Earnest Partners Llc decreased Mednax Inc (MD) stake by 2.3% reported in 2018Q4 SEC filing. Earnest Partners Llc sold 44,607 shares as Mednax Inc (MD)’s stock declined 18.39%. The Earnest Partners Llc holds 1.90 million shares with $62.61M value, down from 1.94M last quarter. Mednax Inc now has $2.23 billion valuation. The stock decreased 2.53% or $0.67 during the last trading session, reaching $25.99. About 107,762 shares traded. MEDNAX, Inc. (NYSE:MD) has declined 39.48% since April 17, 2018 and is downtrending. It has underperformed by 43.85% the SP500. Some Historical MD News: 16/05/2018 – Mednax Presenting at Bank of America Conference Tomorrow; 30/04/2018 – Mednax 1Q EPS 68c; 08/03/2018 – MEDNAX SPIKES AS MUCH AS 10% BEFORE PARING GAINS; 21/03/2018 – MEDNAX INC – ANNOUNCED ACQUISITION OF CHILDREN’S EYE CARE, LLC, A PRIVATE PEDIATRIC OPHTHALMOLOGY PRACTICE; 08/03/2018 – HELLMAN FRIEDMAN IS ALSO SAID TO MAKE INDICATIVE MEDNAX BID; 02/04/2018

... read more at: